ClearanceBrief
510(k) K991127 ยท JPD Hemoglobin A2 Quantitation

VARIANT II B-THALASSEMIA

ApplicantBio-Rad, Hercules CA, US
DecisionSubstantially Equivalent, Jun 10, 1999
ReceivedApr 2, 1999
TypeSpecial
FDA recordOpen on fda.gov

Recalls that name K991127

DateFirm and productCodeLinked 510(k)
May 2, 2014Bio-Rad Laboratories, Inc.
Variant II beta-thalassemia Short Program Model Numbers 270-2103 (250 tests) and 270-2154 (500 tests), Bio-Rad Laboratories, Inc. in vitro diagnostic. The Variant II Hemoglobin testing system uses t
Terminated
JPDNone listed
Oct 7, 2011Bio-Rad Laboratories, Inc.
VARIANT B-thalassemia Short Program Reorder Pack, 250 Tests, For the separation and determination os HbA and HbF and as an aid in the identification of abnormal hemoglobins in whole blood. IVD, Made
Terminated
LCPNone listed
Oct 7, 2011Bio-Rad Laboratories, Inc.
VARIANT B-thalassemia Short Program Reorder Pack, 500 Tests, For the separation and determination of HbA and HbF and as an aid in the identification of abnormal hemoglobins in whole blood. IVD, Made
Terminated
LCPNone listed
Oct 7, 2011Bio-Rad Laboratories, Inc.
VARIANT / VARIANT II B-thalassemia Short Program Elution Buffer 2,. Made in United States. Bio-Rad Laboratories, Hercules, CA 94547. Percentage determination of hemoglobin A1c in human whole blood u
Terminated
LCPNone listed

Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.